Having a Mocktail Instead of a Cocktail Could Reduce Your Risk for Developing 7 Known Types of Cancer | Newswise

Having a Mocktail Instead of a Cocktail Could Reduce Your Risk for Developing 7 Known Types of Cancer | Newswise

Newswise — MIAMI, FLORIDA (Jan. 15, 2025) – The U.S. Surgeon General has recommended that alcoholic beverages carry cancer risk warning labels, citing a growing body of research that shows alcohol as a group 1 carcinogen. But more than half of U.S. residents don’t know that alcohol consumption increases their risk of developing cancer, or…

Read More
ASH 2024: Antibody Shows Encouraging Results for T | Newswise

ASH 2024: Antibody Shows Encouraging Results for T | Newswise

Newswise — MIAMI, FLORIDA (STRICTLY EMBARGOED UNTIL DEC. 8, 2024, AT 12 NOON EST) – Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and marginal zone lymphoma. The findings, led by physician-scientists at Sylvester Comprehensive Cancer Center, part of…

Read More
ASH 2024: Antibody Shows Encouraging Results for T | Newswise

Sylvester Cancer Tip Sheet – Nov 2024 | Newswise

November Tip Sheet  CANCER RESEARCH Sylvester Researchers to Share Insights at ASH 2024 Annual Meeting Dozens of physician-scientists and other investigators from Sylvester Cancer will share their insights at ASH 2024, the American Society of Hematology’s 66th-annual meeting in San Diego, Dec. 7-10. Sylvester researchers will be involved in more than 130 presentations, including oral,…

Read More